Making drug development predictable.

Experts in AI, biology and clinical development, building models to predict human responses and clinical trial outcomes.

Meet our team

Jeff Leek, PhD

CEO & Co-Founder

Alice Walsh, PhD

COO

Robert Bradley, PhD

Co-Founder & Scientific Advisor

Gregory Koytiger, PhD

Vice President of AI

Stein Setvik

Vice President of Engineering

Liza Ray, MBA

Chief of Staff & Vice President of Business Operations

Ariel Brumbaugh, PhD

Senior Director of Business Development

Alex Abbas, PhD

Director of Computational Biology

Alex David

Software Engineer

Alexa Rust

Full Stack Engineer

Candace Savonen, MS

Bioinformatics Data Engineer

John Johnson, PhD

Principal Computational Biologist

Kaspar Märtens, PhD

Principal AI Researcher

Kayla Johnson, PhD

Computational Biologist

Krishna Yerramsetty, PhD

Principal AI Researcher

Lauren Beck, PhD

Principal Computational Biologist

Supported by

  • AI House
  • Sahsen
  • Madrona
  • Inner Loop Capital
  • Point Field Partners

Programs

  • Claude
  • NVIDIA Inception Program
  • Ginkgo Datapoints

Where biology meets AI

We’re looking for experts at the intersection of AI and biology to make biopharma more predictable.

Explore open roles

Partner with us

Synthesize Bio enables teams to explore broader research spaces and make faster, more confident drug development decisions. We are actively engaging with biopharma partners to deploy these capabilities at scale.